More info
Hypercholesterolemia, serum lipoprotein levels, and atherosclerosis
Decreased risk factors: hypercholesterolemia, atherosclerosis, hypertension, mortality from cardiovascular disease.
LDL cholesterol reduction
Triglyceride reduction and HDL increase
Rusty LDL reduction.
LDL cholesterol reduction
Triglyceride reduction and HDL increase
Rusty LDL reduction.
Arterial hypertension
Decreased diastolic and systolic pressure in hypertensive and normotensive subjects.
Prevention of damage to the vascular endothelium.
Thrombotic Profile
Inhibition of blood clot formation due to decreased monocyte adhesion and increased fribrinolysis.
Platelet aggregation inhibition.
Reduction of thromboxane TXB2 and leukotriene LTB4 in hyperlipidemic subjects and patients with type 2 diabetes.
Improvement of endothelial function.
Oxidation and oxidative stress
Preserves cellular integrity and reduces effects of age.
Anti-inflammatory and vasodilatory action.
Delays onset of atherosclerosis.
Prevents oxidation of cell membranes and plasma lipoproteins.
Reduces free radical production, prevents damage to cell membranes, mitochondria, DNA.
Inflammation
Anti-inflammatory action through non-selective inhibition of COX-1 and COX-2 enzymes.
Protection against different pathologies such as tumors of the colon, stomach, breast, prostate, lung and Alzheimer's disease.
Obesity and diabetes
Risk reduction by inhibition of NF-kbeta.
Protection of mitochondria, reduction of free radicals, protection against oxidation of DNA.
Improves insulin sensitivity.
Reduction of insulin requirements, improvement of lipid profile and glycemic index.
Benefits for obese by inhibiting inflammatory response.
Cancer
Cancer incidence reduction
Anti-tumor activity
HER2 oncogenic gene inhibition
Increases inhibitory effect of Herceptin on breast cancer cells
Other benefits
Increased feeling of satiety.
